Project Grant R01AI187384
Award Date 8/11/25
Completion Date 7/31/30
Dollars Obligated $769K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
William Penn Annex West, PA 19107, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,121,542 Project Grant under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) to The Johns Hopkins University. The purpose of this 4-year project, starting on August 1, 2025, is to develop and utilize animal models and novel positron emission tomography (PET) imaging techniques to study Staphylococcus aureus (S. aureus) orthopedic implant-associated infections. This research aims to...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, provides $447,783 to the University of Pittsburgh to conduct preclinical research on prosthetic joint infections (PJI) and the use of bacteriophage therapy as a novel treatment. The key objectives are to: 1) evaluate the clonality of S. aureus PJI infections using whole genome sequencing, 2) visualize biofilm...
- The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), awarded a $490,093 Project Grant to the University of Maryland, College Park on April 10, 2025. The funding supports the development of a rapid, inexpensive microfluidic technology to isolate bacteria directly from whole blood, identify pathogens, and evaluate their antibiotic response within 75 minutes. This will enable clinicians to move...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,201,716 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Rector & Visitors of the University of Virginia (UVA). The grant, effective August 6, 2025 through July 31, 2030, aims to develop and apply innovative high-throughput screening platforms to measure the accumulation of small molecules in the multidrug-resistant pathogen Acinetobacter baumannii (A. baumannii)....
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $158,500 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Temple University to conduct an exploratory study on a new pH-responsive, ionizable hybrid nanocarrier for enhancing drug delivery to bacterial biofilms. The goal is to develop a nanocarrier design that can effectively deliver a range of therapeutic agents to biofilms, which are the main cause of chronic wound infections...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $212,169 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to The Johns Hopkins University to advance mentorship at the Johns Hopkins Integrated Center for Combating Antimicrobial Resistant Bacteria. The project summary indicates the principal investigator has conducted pivotal research on antimicrobial resistant infections, leading to clinical guidelines, and has...
- This $392,634 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of a novel nanoimmunotherapeutic approach to combat multidrug-resistant (MDR) bacterial infections. The project aims to design, fabricate, and optimize a red blood cell membrane-coated, hemoglobin-encapsulating nanoparticle (RHNP) that can sensitize bacteria to host oxidant killing while...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $254,478 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The University of Texas Southwestern Medical Center to identify mechanisms of resistance to pathogen-specific antibacterial antisense compounds and develop strategies to circumvent them. The project aims to determine the resistance mechanisms for lead peptide-phosphorodiamidate morpholino oligomers (PPMOs) against...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $593,860 Project Grant through the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Massachusetts (UMass) for the development of new polymer-phage conjugate nanoparticles to treat antibiotic-resistant wound biofilm infections. The 5-year project, which began on June 6, 2025, seeks to create phage-polymer nanoparticles that can effectively penetrate and eradicate biofilm infections...
- This $427,625 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the causes of treatment failure for hypervirulent Klebsiella pneumoniae liver abscesses. The research aims to visualize antibiotic distribution and the role of antibiotic-tolerant bacterial cells in this treatment failure, as well as examine the transcriptional profile of the bacteria in...